Malvern, Pennsylvania
United States
7
2020-01-16
7
2022-03-15
These are the the leading inventors for applications assigned to Progenra, Inc.:
Progenra, Inc. based in Malvern, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Azole compounds as ubiquitin-specific protease USP7 inhibitors
#2 | 2018-08-16 ✅ Patent 10,292,973 granted on 2019-05-21Covalent irreversible inhibitors of USP7 as anti-cancer agents
#3 | 2017-08-01 ✅ Patent 9,717,717 granted on 2017-08-01Methods of treating cancer through the inhibition of USP7 and immune system modulation
#4 | 2014-03-13 ✅ Patent 9,382,574 granted on 2016-07-05Di- and poly-ubiquitin deubiquitinase substrates and uses thereof
#5 | 2012-05-03 ✅ Patent 8,518,660 granted on 2013-08-27Di- and poly-ubiquitin deubiquitinase substrates and uses thereof
#6 | 2012-03-15 ✅ Patent 8,691,958 granted on 2014-04-08Methods and compositions for enhanced protein expression and purification
#7 | 2006-02-23 ✅ Patent 7,842,460 granted on 2010-11-30Method for assessing proteolytic enzyme activity using ubiquitin fusion substrate
Also check out PROGENRA, INC.'s (Malvern, United States) applicant profile with 4 patent applications submitted.
58159 ⎘